← PUMA BIOTECHNOLOGY, INC.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Attributable to Parent ($276.0m) ($292.0m) ($113.6m) ($75.6m) ($60.0m) ($29.1m) $2k $21.6m $30.3m $31.1m
Net Income (Loss) Available to Common Stockholders, Basic ($276.0m) ($292.0m) ($113.6m) ($75.6m) ($60.0m) ($29.1m) $2k $21.6m $30.3m $31.1m
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest — — ($113.6m) ($75.6m) ($60.0m) — — — — —
Depreciation and amortization $1.1m $2.8m $7.4m $8.1m $10.0m $10.6m $8.9m $11.5m $11.5m $10.9m
Depreciation $1.1m $2.8m $7.4m $900k $900k $700k $600k $400k $400k $400k
Amortization of Debt Issuance Costs — — — — $2.0m $2.6m $1.2m $1.3m — —
Amortization of Intangible Assets — $1.6m $3.9m $3.9m $6.3m $8.0m $8.0m $9.7m $9.7m $9.7m
Deferred Income Tax Expense (Benefit) — — — — — — — — ($7.1m) $3.2m
Deferred income taxes — — — — — — — $0 ($7.1m) $3.2m
Share-based Payment Arrangement, Noncash Expense $117.3m $108.7m $86.9m $57.3m $36.6m $32.6m $11.8m $10.2m $8.2m $6.9m
Share-based Payment Arrangement, Expense — — — — — $32.6m $11.8m $10.2m $8.2m $6.9m
Gain (Loss) on Sale of Assets and Asset Impairment Charges — — — ($1.2m) — — — — — —
Operating Lease, Impairment Loss — — — — — $0 $0 — — —
Loss on impairment of asset — — — $1.2m $0 $0 $0 $625k $0 $0
Gain (Loss) on Disposition of Assets ($368k) — — — — — — — — —
Gain (Loss) on Disposition of Property Plant Equipment — — — ($54k) $0 ($1k) ($1k) $0 $0 ($4k)
Gain (Loss) on Extinguishment of Debt — — — ($8.0m) — ($8.1m) $0 $0 — —
Income Tax Expense (Benefit) $0 $0 $17k $53k $207k $324k $455k $1.1m ($6.2m) $4.7m
Interest Expense Nonoperating — — — — — — — — $12.5m $6.6m
Operating Lease, Expense — — — — — $5.1m $4.9m $4.9m $4.9m $4.5m
Other Nonoperating Income (Expense) ($373k) ($101k) ($714k) $128k $367k $292k ($28k) $759k $862k $1.0m
Operating lease assets and liabilities, net — — — — — ($707k) ($920k) ($1.2m) ($1.6m) ($1.8m)
Changes in operating assets and liabilities:
Additional Financial Items
Increase (Decrease) in Accounts Receivable — $9.7m $11.1m $8.1m ($2.4m) $6.0m $7.8m $8.4m ($16.3m) $21.3m
Increase (Decrease) in Inventories — $2.0m $596k $545k $284k $3.7m ($2.6m) $2.6m $1.6m ($3.2m)
Increase (Decrease) in Accounts Payable $2.2m $7.7m ($7.0m) ($1.5m) ($7.1m) ($902k) ($4.7m) $449k ($1.4m) ($453k)
Proceeds from Stock Options Exercised $576k — — — — — — — — —
General and Administrative Expense $53.8m — — — — — — — — —
Investment Income, Interest $958k $1.3m $1.8m $2.8m $489k $160k $813k $2.6m $4.7m $4.1m
Nonoperating Income (Expense) $585k $435k ($18.9m) ($36.5m) ($29.4m) ($30.1m) ($23.3m) ($10.0m) ($6.9m) ($1.5m)
Operating Expenses $276.6m $320.1m $345.7m $311.4m $255.5m — — — — —
Stock-based compensation $117.3m $108.7m $86.9m $57.3m $36.6m $32.6m $11.8m $10.2m $8.2m $6.9m
Provision for credit loss recovery — — — $0 $1.0m $0 $0 $881k ($519k) ($362k)
Accounts receivable, net — ($9.7m) ($11.1m) ($8.1m) $2.4m ($6.0m) ($7.8m) ($8.4m) $16.3m ($21.3m)
Inventory, net — ($2.0m) ($596k) ($545k) ($284k) ($3.7m) $2.6m ($2.6m) ($1.6m) $3.2m
Prepaid expenses and other $3.4m ($1.1m) ($840k) $568k $2.3m $2.7m $2.4m $820k $1.0m ($325k)
Other current assets — — ($1.8m) $1.5m ($3.1m) $3.2m ($2.0m) $1.5m $821k ($165k)
Accounts payable $2.2m $7.7m ($7.0m) ($1.5m) ($7.1m) ($902k) ($4.7m) $449k ($1.4m) ($453k)
Accrued expenses and other — — $15.8m $22.6m $19.3m $5.2m ($33.1m) ($7.6m) ($15.8m) $13.2m
Post-marketing commitment liability — — — $9.0m ($140k) ($1.1m) ($921k) ($940k) ($1.3m) ($2.4m)
Purchase of available-for-sale securities ($81.8m) ($79.7m) ($107.5m) ($127.2m) ($29.8m) ($38.1m) ($4.8m) ($23.8m) ($76.2m) ($108.1m)
Maturity of available-for-sale securities — $114.7m $50.5m $104.5m $73.3m $27.2m $18.9m $17.3m $55.8m $72.0m
Purchase of intangible assets — ($50.0m) — $0 ($20.0m) $0 $0 ($12.5m) $0 $0
Net proceeds from shares issued under employee stock plans $576k $26.7m $7.7m $1.4m $68k $0 $0 $0 $150k $130k
Payment of exit costs — — — ($7.8m) — — $0 $0 ($666k) ($888k)
Net Cash Provided by (Used in) Operating Activities ($141.7m) ($172.5m) ($24.1m) $22.4m $773k $20.6m ($15.8m) $27.0m $38.9m $41.8m
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $4.3m $431k $439k $25k ($46k) $0 $0 $140k $56k $71k
Net Cash Provided by (Used in) Investing Activities $142.2m ($15.4m) ($57.6m) $5.2m $23.4m ($10.9m) $7.1m ($19.1m) ($20.4m) ($36.2m)
Cash flows from financing activities:
Proceeds from Issuance of Long-term Debt — $50.0m $105.0m $25.0m — — — — — —
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale — — — $104.5m $73.3m $27.2m $18.9m $17.3m $55.8m $72.0m
Payment of debt — — — ($80.0m) ($8.4m) ($100.0m) $0 $0 ($33.3m) ($44.4m)
Proceeds from Issuance of Common Stock $161.9m — — — — — — — — —
Net Cash Provided by (Used in) Financing Activities $162.4m $75.1m $108.5m ($67.1m) $68k ($31.9m) $12.2m $0 ($33.8m) ($45.2m)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect — — $26.7m ($39.5m) $24.2m ($22.2m) $3.5m $7.9m ($15.4m) ($39.6m)
Net (decrease) increase in cash, cash equivalents and restricted cash $162.9m ($112.8m) $26.7m ($39.5m) $24.2m ($22.2m) $3.5m $7.9m ($15.4m) ($39.6m)
Cash, Cash Equivalents, and Short-term Investments $229.4m $81.7m — — — $69.8m $46.5m $48.9m $86.8m $91.6m
Cash, cash equivalents and restricted cash, beginning of period $198.8m $86.0m $112.7m $73.2m $97.5m $75.3m $78.8m $86.7m $71.3m $31.7m
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities — $334k $8.1m $11.7m $9.7m $10.3m $10.3m $11.6m $10.8m $5.8m
Income Taxes Paid, Net — — $17k $53k $207k $324k $384k $737k $1.2m $1.3m

Data sourced from SEC EDGAR 10-K filings via EdgarTools. Amounts are shown in USD as reported in each fiscal year filing.